机械按压与手动按压在心脏骤停中的疗效与安全性:一项贝叶斯网络Meta分析
该贝叶斯网络Meta分析纳入7项随机对照试验,比较机械按压装置(AutoPulse和LUCAS)与手动按压在心脏骤停患者心肺复苏中的相对疗效与安全性。共分析12908例患者,其中AutoPulse组2608例、LUCAS组3308例、手动按压组6992例。结果显示,手动按压较AutoPulse改善30天或出院存活(OR 1.40,95% Cr I 1.09-1.94)和神经功能恢复(OR 1.51,95% Cr I 1.06-2.39);LUCAS与AutoPulse在入院存活、神经功能恢复或ROSC方面无差异。手动按压降低气胸风险(OR 0.56,95% Cr I 0.33-0.97),手动按压(OR 0.15,95% Cr I 0.01-0.73)和LUCAS(OR 0.07,95% Cr I 0.00-0.43)均较AutoPulse降低血肿形成风险。概率分析将手动按压列为改善30天或出院存活最有效的治疗(SUCRA 84%)。
要点
- 手动按压较AutoPulse改善30天或出院存活(OR 1.40,95% Cr I 1.09-1.94)和神经功能恢复(OR 1.51,95% Cr I 1.06-2.39)。
- LUCAS与AutoPulse在入院存活、神经功能恢复或ROSC方面无差异。
- 手动按压较AutoPulse降低气胸风险(OR 0.56,95% Cr I 0.33-0.97)。
- 手动按压(OR 0.15,95% Cr I 0.01-0.73)和LUCAS(OR 0.07,95% Cr I 0.00-0.43)均较AutoPulse降低血肿形成风险。
- 概率分析将手动按压列为改善30天或出院存活最有效的治疗(SUCRA 84%)。
适用人群与场景
- 接受心肺复苏的心脏骤停患者,汇总自7项随机对照试验。
研究设计与关键结果
- 研究类型为贝叶斯网络Meta分析,纳入7项随机对照试验,检索PubMed/Medline、EMBASE和CENTRAL(建库至2017年10月31日)。
- 共分析12908例心脏骤停患者:AutoPulse组2608例、LUCAS组3308例、手动按压组6992例。
- 手动按压较AutoPulse改善30天或出院存活(OR 1.40,95% Cr I 1.09-1.94)和神经功能恢复(OR 1.51,95% Cr I 1.06-2.39)。
- LUCAS与AutoPulse在入院存活、神经功能恢复或ROSC方面无差异。
- 手动按压较AutoPulse降低气胸风险(OR 0.56,95% Cr I 0.33-0.97);手动按压(OR 0.15,95% Cr I 0.01-0.73)和LUCAS(OR 0.07,95% Cr I 0.00-0.43)均较AutoPulse降低血肿形成风险。
- 概率分析将手动按压列为改善30天或出院存活最有效的治疗(SUCRA 84%)。
证据类型、等级与局限
- 证据类型:贝叶斯网络Meta分析,纳入7项随机对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,手动按压在改善30天或出院存活和神经功能恢复方面优于AutoPulse,与LUCAS相当。
- 作者认为,手动按压较AutoPulse气胸或血肿形成风险更低。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To compare relative efficacy and safety of mechanical compression devices (AutoPulse and LUCAS) with manual compression in patients with cardiac arrest undergoing cardiopulmonary resuscitation (CPR).
METHODS: For this Bayesian network meta-analysis, seven randomized controlled trials (RCTs) were selected using PubMed/Medline, EMBASE, and CENTRAL (Inception- 31 October 2017). For all the outcomes, median estimate of odds ratio (OR) from the posterior distribution with corresponding 95% credible interval (Cr I) was calculated. Markov chain Monte Carlo (MCMC) modeling was used to estimate the relative ranking probability of each intervention based on surface under the cumulative ranking curve (SUCRA).
RESULTS: In analysis of 12, 908 patients with cardiac arrest [AutoPulse (2, 608 patients); LUCAS (3, 308 patients) and manual compression (6, 992 patients)], manual compression improved survival at 30 days or hospital discharge (OR, 1.40, 95% Cr I, 1.09-1.94), and neurological recovery (OR, 1.51, 95% Cr I, 1.06-2.39) compared to AutoPulse. There were no differences between LUCAS and AutoPulse with regards to survival to hospital admission, neurological recovery or return of spontaneous circulation (ROSC). Manual compression reduced the risk of pneumothorax (OR, 0.56, 95% Cr I, 0.33-0.97); while, both manual compression (OR, 0.15, 95% Cr I, 0.01-0.73) and LUCAS (OR, 0.07, 95% Cr I, 0.00-0.43) reduced the risk of hematoma formation compared to AutoPulse. Probability analysis ranked manual compression as the most effective treatment for improving survival at 30 days or hospital discharge (SUCRA, 84%).
CONCLUSIONS: Manual compression is more effective than AutoPulse and comparable to LUCAS in improving survival at 30 days or hospital discharge and neurological recovery. Manual compression had lesser risk of pneumothorax or hematoma formation compared to AutoPulse.
参考来源
- Khan SU, Lone AN, Talluri S, et al. Efficacy and safety of mechanical versus manual compression in cardiac arrest - A Bayesian network meta-analysis. Resuscitation. 2018. PMID: 29746986. doi:10.1016/j.resuscitation.2018.05.005
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。